Aldatu Biosciences Inc. provides diagnostics to detect drug resistance in antiretroviral treatments for HIV. The company offers diagnostics using its PANDAA, a pan degenerate amplification and adaptation platform technology. Its PANDAA HIV genotyping empowers healthcare providers with a solution to match HIV patients with drugs to improving patient outcomes and reducing the per-patient cost of HIV care. Aldatu Biosciences Inc. was incorporated in 2014 and is based in Cambridge, Massachusetts.